SCM
ARNA

Suvretta Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Suvretta Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-245,800
Closed -$22.8M – 111
2021
Q4 		$22.8M Sell
245,800
-261,288
-52% -$17.2M 0.44% 48
2021
Q3 		$30.2M Buy
+507,088
New +$30M 0.51% 42
2020
Q2 		– Sell
-26,200
Closed -$1.1M – 106
2020
Q1 		$1.1M Buy
+26,200
New +$1.2M 0.03% 48

Suvretta Capital Management's ARNA Position: Q1 2022 in Review

Suvretta Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 245,800 shares — an estimated $22.8M sold.

Suvretta Capital Management first reported a position in ARNA in Q1 2020 and held it in 3 quarters. The position peaked at $30.2M in Q3 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Suvretta Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Suvretta Capital Management sold 245,800 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $22.8M.
  • Suvretta Capital Management first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 3 quarters.
  • Suvretta Capital Management's Arena Pharmaceuticals Inc position peaked at $30.2M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Suvretta Capital Management's 13F filing for Q1 2022, filed 16 May 2022.